02256.HK
Abbisko Cayman Limited
HKSE · Healthcare · Biotechnology · CN
HKD 8.77
−1.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.15x
- Price / sales
- 48.25x
- Price / cash flow
- -20.95x
Enterprise value
- Enterprise value
- HKD 3.1B
- EV / sales
- 27.60x
- EV / EBITDA
- -5.27x
- EV / EBIT
- -5.18x
- Market cap
- HKD 5.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026